KPASPA.COM

tithonhuman.com

Vision and Mission | Tithon Human Sciences

http://tithonhuman.com/index/vision-and-mission

Tithon's Vision and Mission. Tithon’s mission is to relieve human suffering resulting from degenerative conditions, including aging and infertility. Through the efforts and dedication of our science team, and those collaborators within the medical community who share our vision and mission, we pursue our mission tirelessly, seeking to provide mankind with new medical solutions. LATEST NEWS AND EVENTS. Subscribe To Our Newsletter. Join our mailing list to receive the latest news and updates. Oct 16, 2016.

tithonhuman.com

Tithon Human Sciences, Inc. Annouces Opening Of Second Tithon Regenerative Centre | Tithon Human Sciences

http://tithonhuman.com/index/2016/09/16/tithon-human-sciences-inc-annouces-opening-of-second-tithon-regenerative-centre-2

Tithon Human Sciences, Inc. Annouces Opening Of Second Tithon Regenerative Centre. Sep 16, 2016. Tithon Human Sciences, Inc., announced the opening of its second Tithon Regenerative Centre located in Kuala Lumpur, Malaysia, providing Asia, India and the Middle East access to Tithon’s advanced cellular technologies developed to address degenerative medical conditions, including aging and infertility. About Tithon Human Sciences, Inc. Your email address will not be published. Required fields are marked *.

tithonanimal.com

Accredited Investor Verification - Tithon Animal Sciences, Inc.

http://tithonanimal.com/index/investment/accredited-investor-verification

Officers, Directors and Advisors. Why we are offering the Investment Opportunity only to Accredited Investors. How we are seeking to comply with this Mandate. To comply with this mandate, we have selected a Third-Party Verification Firm engaged in providing independent verification, based upon each investor’s submission of such information, as required to establish their status as an Accredited Investor. 700 Lavaca St, Suite 1400, Austin, TX 78701. Web Development by Kosta Paspaliaris.

tithonanimal.com

Investment - Tithon Animal Sciences, Inc.

http://tithonanimal.com/index/investment

Officers, Directors and Advisors. And a Common Stock Purchase Warrant. This is a unique opportunity to participate as an investor in a spin-off venture with proven stem cell products as well as newly developed advanced technologies offering new commercial opportunities in the companion animal and equine therapeutic market. If you are an Accredited Investor and interested in further exploring this investment opportunity please select the button below. If you are not sure if you qualify as an Accre...

tithonhuman.com

About | Tithon Human Sciences

http://tithonhuman.com/index/about

Tithon’s research team, in collaboration with university researchers and experts in various medical specialties has:. Undertaken the development of a unique protein that stimulates the expression and activity of cellular telomerase. Developed a unique method for recovering and processing paternal antigens for use in increasing female immune tolerance to the paternal antigen, thereby improving the possibility of natural pregnancy. We possess an independent research team and collaborate with university res...

tithonanimal.com

About - Tithon Animal Sciences, Inc.

http://tithonanimal.com/index/about-us

Officers, Directors and Advisors. The Company is managed by it Chief Executive Officer Mr. Mark Kyle, who is under the direction of the Company’s Board of Directors comprised of Dr. Bill Paspaliaris and Mr. Peter Milonas. The Company also receives support from officers of its parent company, Tithon Biotech including Tithon Biotech’s Chief Financial Officer, Mr. Richard Schmidt, and its Director of Legal and Compliance, Mr. David Strawn. View Officers, Directors and Advisors.

tithonanimal.com

Verification Process - Tithon Animal Sciences, Inc.

http://tithonanimal.com/index/investment/accredited-investor-verification/compliance

Officers, Directors and Advisors. To comply with this mandate, we have selected Early IQ, a San Diego based company, to provide the mandatory independent third party verification of Accredited investor status, based upon each investor’s submission of such information, as required to establish their status as an Accredited Investor. About the Third-Party Verification Firm. Early IQ provides confidential and professional services allowing investors to participate in non-public investments under the newly a...

tithonhuman.com

Tithon Regenerative Centers | Tithon Human Sciences

http://tithonhuman.com/index/tithon-regenerative-centers

Kuala Lumpur, Malaysia. Contact a Tithon Regenerative Center. 11440 W Bernardo Ct, San Diego, CA 92127, USA. 1 888 780 2639. Summary Video of the First Symposium for the AABRM – KL 17-18 December. Dr Paspaliaris Appointed Director To AABRM And President Of Its Asian Chapter. AABRM Announces First International Symposium To Be Held In Kuala Lumpur, Malaysia, Dec. 17-18, 2016. Web Development by Kosta Paspaliaris.

tithonhuman.com

Find a Clinic | Tithon Human Sciences

http://tithonhuman.com/index/find-a-clinic

Boca Raton, FL USA. St Gallen, Switzerland. 11440 W Bernardo Ct, San Diego, CA 92127, USA. 1 888 780 2639. Summary Video of the First Symposium for the AABRM – KL 17-18 December. Dr Paspaliaris Appointed Director To AABRM And President Of Its Asian Chapter. AABRM Announces First International Symposium To Be Held In Kuala Lumpur, Malaysia, Dec. 17-18, 2016. Web Development by Kosta Paspaliaris.

tithonhuman.com

Management and Advisors | Tithon Human Sciences

http://tithonhuman.com/index/management-and-advisors

Dr Vasilis Paspaliaris, BSc(Hons), PhD, MD. Chairman and Chief Executive Officer. Mr Peter Milonas, B(SSc), CEP(APMA). Vice President and Chief Operating Officer. Dr George Kolios, MD, PhD. Chief Scientific and Research Officer. Mr Richard Schmidt, CPA. Mr David Strawn, JD. Director of Legal and Compliance. MEDICAL AND SCIENTIFIC ADVISORY BOARD. Dr Nick Lolatgis, MBBS, FRANZCOG, FRCOG. Obstetrician, Gynecologist, Fertility Specialist. Dr Joseph Purita, MD. Dr Christian Paulos, MD. In 2008, Dr Paspaliaris...